Joint Announcement of Settlement Between
Core-Vent Corporation and Nobelpharma AB
Nobelpharma Core-Vent Corporation
Nobelpharma AB 15821 Ventura Boulevard
Box 5190 Suite 420
S-402 26 GÖTEBORG Encino, CA 91436
Phone: +46 (0)31 81 31 60 USA
FOR IMMEDIATE RELEASE
Joint Announcement of Settlement
LOS ANGELES, CALIFORNIA, January 15, 1989
Mr. Leif Ek, President of Nobelpharma AB, and Dr. Gerald A. Niznick, President of Core-Vent Corporation, announced today that Nobelpharma and Core-Vent Corporation have entered into a confidential settlement of all litigation pending between them.
Nobelpharma has granted Core-Vent Corporation a license under certain of its patents related to dental implants. Core-Vent Corporation has acknowledged that Nobelpharma’s U.S. Patent No. 4,330,891 is valid.
Both companies were pleased to reach an amicable end to the controversy between them.